Circulating Thyroxine, Thyroid-Stimulating Hormone, and Hypothyroid Status and the Risk of Prostate Cancer

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Mondul, Alison M ^a   Weinstein, Stephanie J ^a   Bosworth, Tracey ^b   Remaley, Alan T ^b   Virtamo, Jarmo ^c   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; THYROGLOBULIN; THYROTROPIN; THYROXINE;

AGED; ARTICLE; BLOOD SAMPLING; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EUTHYROIDISM; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; THYROGLOBULIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

AGED; ALPHA-TOCOPHEROL; BETA CAROTENE; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE;

EID: 84868110103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047730     Document Type: Article

References (20)

1. Hercbergs A, (1996) The thyroid gland as an intrinsic biologic response-modifier in advanced neoplasia-a novel paradigm. In Vivo 10: 245-247.
2. Pinto M, Soares P, Ribatti D, (2011) Thyroid hormone as a regulator of tumor induced angiogenesis. Cancer Lett 301: 119-126.
3. Hsieh ML, Juang HH, (2005) Cell growth effects of triiodothyronine and expression of thyroid hormone receptor in prostate carcinoma cells. J Androl 26: 422-428.
4. Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH, (2008) Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 68: 610-619.
5. Yen PM, (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142.
6. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, et al. (2002) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8: 457-469.
7. Lehrer S, Diamond EJ, Stone NN, Stock RG, (2005) Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer. BJU Int 96: 328-329.
8. Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG, (2002) Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia. J Urol 168: 2431-2433.
9. Hoption Cann SA, Qiu Z, van Netten C, (2007) A prospective study of iodine status, thyroid function, and prostate cancer risk: follow-up of the First National Health and Nutrition Examination Survey. Nutr Cancer 58: 28-34.
10. Hellevik AI, Asvold BO, Bjoro T, Romundstad PR, Nilsen TI, et al. (2009) Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev 18: 570-574.
11. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 4: 1-10.
12. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, et al. (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 41: 381-388.
13. Shishiba Y, Umezu Y, Ohtsuki N, (1983) Clinical evaluation of free thyroxine calculation from thyroxine and thyroxine binding globulin radioimmunoassays. Eur J Nucl Med 8: 1-3.
14. Kumar CC, (2003) Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets 4: 123-131.
15. Asvold BO, Bjoro T, Nilsen TI, Vatten LJ, (2007) Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 167: 1428-1432.
16. Belin RM, Astor BC, Powe NR, Ladenson PW, (2004) Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 89: 6077-6086.
17. Jorde R, Sundsfjord J, (2006) Serum TSH levels in smokers and non-smokers. The 5th Tromso study. Exp Clin Endocrinol Diabetes 114: 343-347.
18. Mehran L, Amouzgar A, Delshad H, Azizi F, (2012) The Association of Cigarette Smoking with Serum TSH Concentration and Thyroperoxidase Antibody. Exp Clin Endocrinol Diabetes.
19. Monaco HL, (2000) The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 1482: 65-72.
20. Albanes D, Virtamo J, Taylor PR, Rautalahti M, Pietinen P, et al. (1997) Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 66: 366-372.